Clinical Longevity of 106,462 Rechargeable and Primary Cell Spinal Cord Stimulators: Real World Study in the Medicare Population
Timothy R. Deer(The Spine & Nerve Centers of the Virginias), Paul Verrills(Metro South Health), Julie G. Pilitsis(University of Arizona), Corey Hunter(Ainsworth Institute of Pain Management), Steven Falowski, Allison T. Connolly(Danaher (United States)), Allen W. Burton(Abbott (United States)), Jason E. Pope(Evolve Restorative Center)
Cited by 28
Related Papers
Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain
|Anesthesiology|2015|838
Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial
|The Lancet Psychiatry|2017|565
Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition
|Pain Medicine|2013|533
Success Using Neuromodulation With BURST (SUNBURST) Study: Results From a Prospective, Randomized Controlled Trial Using a Novel Burst Waveform
|Neuromodulation Technology at the Neural Interface|2017|451